Johnson & Johnson Institute Delivers Immersive-Digital Experience
More than 600 members of the Electrophysiology community (EP) from across Europe and the globe took part in the Practical Sessions of the AFIB Symposium #AFIB2021. Presented by the Johnson & Johnson Institute and Biosense Webster, the annual program was held virtually this year and featured many new components to engage participants and advance care for patients with AFIB, the world’s most common cardiac arrhythmia.
Interactive Demonstration of Heart Anatomy
For the first time, the event included a demonstration on a cadaveric specimen to show the anatomy of the heart in situ (i.e, normal position). By way of a camera mounted on the tip of a catheter, faculty instructors were for instance, able to show the attendees a view of the heart and surrounding structures from the inside of the human body.
Content Shaped by Participants
Workflow optimization in the EP lab is crucial to improving patient outcomes and reducing costs for the use of catheter ablation to treat Atrial Fibrillation. A roundtable discussion focused on the most common difficulties in the EP lab workflow was shaped by input provided by participants at the AFIB Symposium Scientific Sessions that took place earlier in the year. The course faculty used this feedback to lead an engaging discussion to address the audience’s most pressing concerns.
Given the challenges of the COVID-19 pandemic, this year the AFIB Symposium was reinvented as a series of immersive, digital-only experiences across the year. The March scientific sessions content is now available on demand on the #AFIB2021 hub, with the content from the Practical Sessions to be available shortly. Please note registration and content for this program is not intended for US Healthcare Providers due to regulatory limitations.
“Each year this symposium plays host to cutting edge thinking and practice from the field,” said Tamer Shawky, Senior Director Education Solutions, Johnson & Johnson Institute. “In these unprecedented times, we were proud to be able to deliver this program in an engaging, virtual format that allowed more participants to share new perspectives to advance AFIB treatment.”
© Johnson & Johnson Services, Inc. 2021. All rights reserved. 182269-210706